|

6-Mercaptopurine Clinical Trials

6 actively recruiting trials across 1 location

▼ -1 trial since May 2026

Also known as: 6-MP, Mercaptopurine

Pipeline

Phase 1: 1Phase 2: 3Phase 3: 2

Top Sponsors

  • Institute of Hematology & Blood Diseases Hospital, China2
  • University Hospital, Antwerp1
  • University Hospital Muenster1
  • St. Jude Children's Research Hospital1
  • Martin Schrappe1

Indications

  • Cancer6
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma2
  • Lymphoblastic Lymphoma, Childhood1
  • Acute Myeloid Leukemia, in Relapse1
  • Acute Lymphoblastic Leukemia, Pediatric1

Other5 trials

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
Phase 2
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3
Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
Phase 2
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3
Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia
Phase 1

Tulsa, Oklahoma1 trial

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Saint Francis Children's Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.